Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Business Times.
Press releases published on May 5, 2025

American Tungsten Corp. Announces Changes to Board of Directors
Vancouver, BC, May 05, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) announces today the appointment of Dan Nicholas to the Board of Directors of the Company (the “Board”), and …

Tyson Foods Reports Second Quarter 2025 Results
SPRINGDALE, Ark., May 05, 2025 (GLOBE NEWSWIRE) -- Tyson Foods, Inc. (NYSE: TSN), one of the world’s largest food companies and a recognized leader in protein with leading brands including Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Wright, Aidells, ibp …

Goliath Resources Engages JDS Energy & Mining Inc. To Forge Plans To Drive An Exploration Adit At Its Surebet Discovery, Golddigger Property, Golden Triangle, B.C.
Drill-out of all high-grade Surebet lodes will be more easily and cheaply facilitated from underground vantages. Underground access to the Bonanza Zone will enable geological confirmation of this important high-grade lode and potentially enable bulk …

USA Rare Earth Announces Closing of $75 Million PIPE Financing
STILLWATER, Okla., May 05, 2025 (GLOBE NEWSWIRE) -- USA Rare Earth, Inc. (Nasdaq: USAR) (USAR or the Company), today announced the closing of its previously announced private investment in public equity (PIPE) financing. The PIPE is with a single …

BioCryst Reports First Quarter 2025 Financial Results and Provides Business Update
—Q1 2025 ORLADEYO net revenue of $134.2 million (+51 percent y-o-y)— —Full year 2025 ORLADEYO revenue guidance increased to $580 million to $600 million— —Company now expects to be profitable for full year 2025, a year ahead of schedule— —Company pays down …

Ichnos Glenmark Innovation (IGI) Receives U.S. FDA Fast Track Designation for ISB 2001 for Relapsed/Refractory Multiple Myeloma
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- IGI, Inc., a global, fully integrated clinical-stage biotechnology company focused on developing multispecifics™ in oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track …

IRADIMED CORPORATION Announces First Quarter 2025 Financial Results
Announces Regular Quarterly Cash Dividend of $0.17 Per Share Reaffirms Full Year 2025 Revenue and Earnings Guidance Reports record revenue of $19.5 million for the first quarter of 2025, an increase of $1.9 million or 11%, compared to the same period in …

Foghorn Therapeutics to Participate in the Citizens Life Sciences Conference
CAMBRIDGE, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced …

Apollo Silver Appoints Ross McElroy as President and CEO
VANCOUVER, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) -- Apollo Silver Corp. (“Apollo” or the “Company”) (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF0) is pleased to announce the appointment of Mr. Ross McElroy as President and CEO, effective immediately, …

Ocular Therapeutix™ Reports First Quarter 2025 Results and Business Highlights
AXPAXLI™ SOL trials for wet AMD progressing rapidly following recent updates to accelerate and enhance the registrational program Following positive FDA feedback for potential AXPAXLI NPDR registrational trial, Ocular is actively planning next steps in …

Grassy Mountain Gold Project Selected for US Government FAST-41 Program
WINNEMUCCA, Nev., May 05, 2025 (GLOBE NEWSWIRE) -- Paramount Gold Nevada Corp. (NYSE American: PZG) (“Paramount” or the “Company”) announced today that the high-grade Grassy Mountain gold project in Malheur County, Oregon, has been selected for inclusion …

Axsome Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
Total 1Q 2025 net product revenue of $121.5 million, representing 62% year-over-year growth AUVELITY® 1Q 2025 net product sales of $96.2 million, representing 80% year-over-year growth SUNOSI® 1Q 2025 net product revenue of $25.2 million, representing 17% …

TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance
First quarter 2025 BRIUMVI U.S. net revenue of $119.7 million Raises full year 2025 global net revenue target to approximately $575 million and raises full year BRIUMVI U.S. net revenue target to approximately $560 million Conference call to be held today, …

Update to Zijin Put Option and Exclusivity Arrangements
TORONTO, May 05, 2025 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu or the Company) refers to its announcement dated 7 April 2025 in relation to the Extension of the Zijin Put Option and Exclusivity Arrangements1 with its major …

Dundee Precious Metals Announces Passing of Chair R. Peter Gillin
TORONTO, May 05, 2025 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX: DPM) (“DPM” or “the Company”) announces with great sadness the passing of R. Peter Gillin, Chair of the Company’s Board of Directors since 2022 and a director for the past 16 years …

Freshpet, Inc. Reports First Quarter 2025 Financial Results
Delivers Approximately 18% Net Sales Growth Strong Operating Performance on Input, Quality and Logistics Costs Updates 2025 Outlook BEDMINSTER, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Freshpet, Inc. (“Freshpet” or the “Company”) (Nasdaq: FRPT) today …

Integra LifeSciences Reports First Quarter 2025 Financial Results
PRINCETON, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2025. First Quarter 2025 …

RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs
APOLLO BEACH, Fla., May 05, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies, Inc. (OTCQB:RTGN) (“RetinalGenix” or the “Company”), announced today a new laboratory lease agreement with life science incubator MBC BioLabs for a brand new facility located …

Recursion Reports First Quarter 2025 Financial Results and Provides Business Update
Pipeline: Delivered on our commitment to a more focused R…

FTI Consulting Strengthens Financial Services Practice Globally with Addition of Seven Senior Professionals
WASHINGTON, May 05, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the expansion of the firm’s Financial Services practice with the appointments of seven senior professionals within the Forensic and Litigation Consulting segment …